May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Inhibition of IL-1 Blocks Corneal Inflammation and Neovascularization
Author Affiliations & Notes
  • J. Cao
    Regeneron Pharm, Inc, Tarrytown, NY, United States
  • R. Renard
    Regeneron Pharm, Inc, Tarrytown, NY, United States
  • H. Song
    Regeneron Pharm, Inc, Tarrytown, NY, United States
  • E. Ioffe
    Regeneron Pharm, Inc, Tarrytown, NY, United States
  • V. Mosher
    Regeneron Pharm, Inc, Tarrytown, NY, United States
  • J.S. Rudge
    Regeneron Pharm, Inc, Tarrytown, NY, United States
  • E.M. Koehler-Stec
    Regeneron Pharm, Inc, Tarrytown, NY, United States
  • G.D. Yancopoulos
    Regeneron Pharm, Inc, Tarrytown, NY, United States
  • S.J. Wiegand
    Regeneron Pharm, Inc, Tarrytown, NY, United States
  • Footnotes
    Commercial Relationships  J. Cao, Regeneron Pharmaceuticals, Inc E; R. Renard, Regeneron Pharmaceuticals, Inc E; H. Song, Regeneron Pharmaceuticals, Inc E; E. Ioffe, Regeneron Pharmaceuticals, Inc E; V. Mosher, Regeneron Pharmaceuticals, Inc E; J.S. Rudge, Regeneron Pharmaceuticals, Inc E; E.M. Koehler-Stec, Regeneron Pharmaceuticals, Inc E; G.D. Yancopoulos, Regeneron Pharmaceuticals, Inc E; S.J. Wiegand, Regeneron Pharmaceuticals, Inc E.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 823. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. Cao, R. Renard, H. Song, E. Ioffe, V. Mosher, J.S. Rudge, E.M. Koehler-Stec, G.D. Yancopoulos, S.J. Wiegand; Inhibition of IL-1 Blocks Corneal Inflammation and Neovascularization . Invest. Ophthalmol. Vis. Sci. 2003;44(13):823.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Systemic administration of a novel IL-1 inhibitor, murine IL-1 Trap, was investigated in a mouse model of corneal injury in order to determine the effect of IL-1 blockade on the development of corneal inflammation and neovascularization. Methods: The murine IL-1 Trap (a chimeric protein comprising the ligand binding domains of murine IL-1R1 and IL-1RacP and mouse Fc) was incorporated into an E1E3 deleted adenovirus (Ad.IL-1 Trap). Twenty-four hours before corneal injury, C57BL/6 mice were injected intravenously with either Ad.IL-1 Trap (1 x 10^9 pfu) or a control adenovirus (adenovirus human Fc). Corneal neovascularization was induced by intrastromal placement of 3 nylon sutures in the right eye. The growth of corneal neovessels was evaluated on days 8 and 15 by slit-lamp microscopy and histology. The vasculature was labeled with an endothelial specific fluorescein conjugated lectin (lycopersicon esculentum), and neovascularization was evaluated in corneal flat-mount, as well as in cross sections using PECAM immunohistochemistry. Corneal edema was also evaluated with slit lamp microscopy and corneal thickness was measured in cross-sections. The number of polymorphonucleocytes (PMN) and macrophages were determined by staining cross-sections with HEMA-3 or rat anti-mouse F4/80 monoclonal antibody, respectively. The Scion Image program was used for analysis of the area and length of corneal neovessels. Circulating levels of murine IL-1 trap were measured on by ELISA 2, 10, and 15 days after the systemic delivery. Results: Treatment with murine IL-1 Trap significantly inhibited corneal edema and neovascularization in suture induced corneal injury (P<0.001). Histological studies showed that IL-1 Trap treatment also dramatically reduced the infiltration of PMNs and macrophages into the damaged cornea. Conclusions: IL-1Trap significantly inhibited the development of corneal neovascularization, effectively prevented edema, and markedly reduced the infiltration of leukocytes and macrophages induced by corneal suture injury. These results indicate that IL-1Trap is a potent inhibitor of inflammation and pathological angiogenesis, with potential therapeutic applications in the treatment of ocular inflammation and neovascularization.

Keywords: neovascularization • cornea: basic science • inflammation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×